(The Business Insider) Viking Global, the $30 billion plus hedge fund led by Andreas Halvorsen, bought more Valeant Pharmaceuticals stock in the fourth quarter even after it dragged down the fund’s performance. Viking Global Equities had a strong 2015 overall, finishing up 8.3% for the year, according to the fund’s fourth quarter letter dated January 14. The average hedge fund finished 2015 down 3.49%.
This Giant Hedge Fund Bought More of its ‘Biggest Loser’
This entry was posted in Syndicated. Bookmark the permalink.
